Apoptosis: Genetically programmed cell death

Genetika

Volumn 40, Issue 2, 2004, Pages 149-166

  Popov, L S ^a   Korochkin, L I ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PROTEIN BCL 2;

APOPTOSIS; CELL DEATH; GENE FUNCTION; GENETICS; MULTIGENE FAMILY; REVIEW; HUMAN;

APOPTOSIS; HUMANS;

EID: 3042745324     PISSN: 00166758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (109)

1. Osborn B.A., Schwartz L.M. Essential genes that regulate apoptosis // Trends in Cell Biol. 1994. V. 4. P. 394-398.
2. Steller H. Apoptosis // Science. 1995. V. 267. P. 1443-1449.
3. Peitch M., Polzaz B., Stephan H. et al. Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death) // EMBO J. 1993. V. 12. P. 371-377.
4. O'Connor L., Huang D.C., O'Reilly L.A. et al. Apoptosis and cell division // Curr. Opin. Cell. Biol. 2000. V. 12. P. 257-263.
5. Rustin P. Mitochondria, from cell death to proliferation // Nature Genet. 2002. V. 30. P. 352-353.
6. Goldstein P. Controling cell death // Science. 1997. V. 275. P. 1031-1037.
7. Joza N., Kroenier G., Penninger J.M. Genetic analysis of the mammalian cell death mashinery // Trends in Genet. 2002. V. 18. P. 142-149.
8. Lin Q.A., Hengarther M.O. The molecular mechanism of programmed cell death in C. elegans // Ann. N.Y. Acad. Sci. 1999. V. 887. P. 92-104.
9. Shwartz L.M., Milligan C.E. Cold throughts of death: the role of ICE proteases in neuronal cell death // Trends in Neurosci. 1996. V. 19. P. 555-562.
10. Clem R.J., Miller L.K. Control of programmed cell death by the baculovirus genes p35 and iap // Mol. Cell Biol. 1994. V. 14. P. 5212-5222.
11. Goyal L., McCall K., Agapite J. et al. Induction of apoptosis by Drosophila reaper, hid and grim through inhibition of IAP function // EMBO J. 2000. V. 19. P. 589-597.
12. Yang E., Zha J., Jockel J. et al. Bad, a heterodimeric partner for BCL-XL and BCL-2, displaces Bax and promotes cell death // Cell. 1995. V. 80. P. 285-291.
13. Theodarakis P., D'sa-Eipper C., Subramanian T. et al. Unmasking of prolifferation restraining activity of the anti-apoptosis // Oncogene. 1996. V. 12. No 8. P. 1707-1713.
14. Kuida K., Zheng T.S., Na S. et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice // Nature. 1996. V. 384. P. 368-372.
15. Lin E., Orlofsky A., Wang H.G. Al, a BCL-2 family member prolongs cell survival, permits myeloid differentiation // Blood. 1996. V. 87. No 3. P. 983-992.
16. Gillet G., Guerin M., Tremblean A. et al. A BCL-2 - related gene is activated in avian cells transformed by the Rous Sarcoma virus // EMBO J. 1995. V. 14. No 7. P. 207.
17. D'Sa-Eipper C., Subramanian G., Chinnadurai G. Bfl-1, a BCL-2 homologue, suppresses p53-induced apoptosis and exhibits potent cooperative transforming activity // Cancer Res. 1996. V. 56. No 17. P. 3879-3882.
18. Han J., Sabbatini P., Perez L. et al. The E1B19K protein blockes apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax // Genes and Develop. 1996. V. 10. No 10. P. 461-477.
19. Takahashi A., Alnemri E.S., Lazebnik Y.A. et al. Cleavage of lamin A by Mch2α but not CPP32: multiple interleukin 1β-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis // Proc. Natl Acad. Sci. USA. 1996. V. 93. P. 8395-8400.
20. Wang H.-G., Mijashika T., Takajama S. et al. Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase // Oncogene. 1994. V. 9. P. 2751-2756.
21. Radvanji L.G., Shi Y., Vaziri H. et al. CD28 costimlation inhibits TCR-induced apoptosis during a primary T cell response. // J. Immunol. 1996. V. 156. No 5. P. 1788-1798.
22. Nagata S., Golstein P. The Fas death factor // Science. 1995. V. 267. P. 1449-1456.
23. Kelley L., Green W., Hicks G. et al. Apoptosis in erythroid progenitors deprived of erithro-poietin occurs during the G1 and S phases of the cell cycle without growth arrest or stabilization of wild type p53 // Mol. and Cell. Biol. 1994. V. 14. No 6. P. 4183-4192.
24. Nakamura Y., Nakanchi H. A trunkated erithropoietin receptor as a dominant negative regulator for cell growth and prevention of apoptosis // Science. 1994. V. 264. P. 588.
25. Orban P.S., Schrader J. Antibodies to an autostimulutory growth factor (IL-2) or its receptor induce death of Ieukemogenic cells. // J. Immunol. 1996. V. 156. P. 3334-3341.
26. Yang B.-C., Chang H.-M., Wang Y.-S. Transient induction of apoptosis in serum-started glioma cells by insulin and IGF-1 // Biochim. Biophys. Acta. 1996. V. 1314. P. 83-92.
27. D'Mello S.R., Galli C., Ciotti T. et al. Induction of apoptosis in cerebellar granul neurons by low potassium: inhibition of death by insulin-like growth factor 1 and cAMF // Proc. Natl Acad. Sci. USA. 1993. V. 90. P. 10989-10993.
28. Minshall C., Arkins S., Frend G.G. et al. Requirement for phosphatidyl-Hemopoietic progenitors against apoptosis dependent upon the extracellular survival factor // J. Immunol. 1996. V. 156. No 2. P. 939-947.
29. Tanaka S., Wands J. Insulin receptor substrate 1 overexpression in human hepftocellular carcinoma cells prevents transforming growth factor β1-induced apoptosis // Cancer Res. 1996. V. 56. No 16. P. 3391-3394.
30. Uren A.C., Pakush M., Howkins Ch. et al. Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and / or bind tumor necrosis factor receptor-associfted factors // Proc. Natl Acad. Sci. USA. 1996. V. 93. No 12. P. 4974-4978.
31. Alarson R.M., Rupnow B.A., Graeber T.G. et al. Modulation of c-myc activity and apoptosis in vivo // Cancer Res. 1996. V. 56. No 18. P. 4315-4319.
32. Yokonchi Y., Sakijama J.-I., Kameda I. et al. BVP-2/-4 mediateprogrammed cell death in chicken limp buds // Development. 1996. V. 122. No 7. P. 3725-3734.
33. Lin J., Lee M.-O., Wang G. et al. Retinoic Acid receptor β mediates the growth-inhibitory effect of retinoic acid by promoting in human breast cancer cells // Mol. Cell. Biol. 1996. V. 16. No 3. P. 1138-1149.
34. Mollerean B., Deckert M., Olivier D. CD2-induced apoptosis in activated human peripheral T-cell // J. Immunol. 1996. V. 156. No 5. P. 3184-3190.
35. Lee S.-H., Fujita N., Mashima T. et al. Interleukin-7 inhibits of mouse malignant T-limphoma cells by suppressing the CPP32-like protease activation and inducing the BCL-2 expression // Oncogene. 1996. V. 13. No 5. P. 2131-2140.
36. Fang G., Ma X., Kren B.T. The retinblastoma gene product inhibits TGF-β1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells // Oncogene. 1996. V. 12. P. 1909-1919.
37. Smith J., Fowkes G., Olmith C. et al. Programmed cell death in dystrophic (Mdx) muscle // The third Euroconference on apoptosis. Cuence. Spain. 1995. poster 69.
38. Bortner D.M., Rosenberg M.P. Overexpression of cyclin A in the mammary glands of transgenic mice results in the induction of nuclear abnormalities and increased apoptosis // Cell. Growth. Differ. 1995. V. 6. P. 1579-1589.
39. Roy N., Mahodevan M.S., McLean M. et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy // Cell. 1995. V. 80. No 1. P. 167-178.
40. Mercer E.A., Korhonen L., Skoglosa Y. et al. NAIP interacts with hippocalcin and protects neurons against calcium-induced cell death through caspase-3 dependent-independent pathways // EMBO J. 2000. V. 19. P. 3597-3607.
41. Liston P., Roy K., Tamai K. et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes // Nature. 1996. V. 379. P. 349-353.
42. Stahlban A. Conference "Cell-signaling and cancer treatment". Telfs-Buchen (Austria), 1997.
43. Rothe M., Pan M.G., Henzel W.J. et al. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins // Cell. 1995. V. 83. P. 1243-1252.
44. Ambrosini G., Adida C., Altieri D.C. A novel antiapoptosis gene surviving, expressed in cancer and lymphoma // Nat. Med. 1997. V. 3. P. 917-921.
45. Hauser H.P., Bardroff M., Pyrowolakis G. Agiant ubiquitin-conjugating enzyme to IAP apoptosis inhibitors // J. Cell. Biol. 1998. V. 141. P. 1415-1422.
46. Lin J.H., Deng G., Huang Q. et al. Kiap, a novel member of the inhibitor of apoptosis protein family // Biochem. Biophys. Res. Commun. 2000. V. 279. P. 820-831.
47. Kasof G.M., Gomes B.C. Livin, a novel inhibitor of apoptosis protein family member // J. Biol. Chem. 2001. V. 276. P. 3228-3246.
48. Vucic D., Stennicke H.R., Pisabarro M.T. et al. ML-IAP, a novel inhibitor of apoptosis, that preferentially expressed in human melanomas // Curr. Biol. 2000. V. 10. P. 1359-1366.
49. Wolf B.M., Green D.R. Apoptosis: letting slip the dogs of dispatch war // Curr. Biol. 2002. V. 12. P. 177-179.
50. Susin S.A., Lorenio H.K., Zanzani N. et al. Molecular characterization of mitochondrial apoptosis-inducing factor // Nature. 1999. V. 397. P. 441-446.
51. Suzuki A., Imai Y., Nakayama H. et al. A serine protease, Htr a2, is released from mitochondria and interacts with XIAP, inducing cell death // Mol. Cell. 2001. V. 8. P. 613-621.
52. Kiselev S.L., Kustikova O.S., Korobko E.V. et al. Molecular cloning and characterization of the mouse tag7 gene eucoding a novel citokine // J. Biol. Chem. 1998. V. 273. P. 18633-18639.
53. Choi S., Park I., Yun J. et al. Bfl-1 is overexpressed in stomach cancer and related gene, prefentially expressed in bone marrow // Oncogene. 1995. V. 11. No 7. P. 1693-1699.
54. Subramanian I., Boid J., Chanadurain G. Functional substitution identifies a cell survival promoting domain common to adenovirus EIB19 kDa and Bcl-2 proteins // Oncogene. 1995. V. 11. No 9. P. 2403-2407.
55. Hunter J.J., Bond B., Parslow T.G. Functional dissection of the human Bcl-2 protein: sequence requirements of inhibition of apoptosis // Mol. Cell. Biol. 1996. V. 16. No 3. P. 877-883.
56. Oltvai Z.N., Millian C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death // Cell. 1993. V. 74. P. 609-619.
57. Oltvai Z.-N., Korsmeyer S.-J. Checkpoints of dueling dimmers foil death wishes // Cell. 1994. V. 79. P. 189-192.
58. Rajapaksa R., Ginzton N., Rott L.S. et al. Altered oncoprotein expression and apoptosis in myelosplastic syndrome marrow cells // Blood. 1996. V. 88. No 1. P. 4275-4287.
59. Zheng T.S., Hunot S., Kuida K. et al. Caspase knockouts: matters of life and death // Cell Death Differ. 1999. V. 6. P. 1043-1053.
60. Bergeron L., Perez G., McDonald G. et al. Defects in regulation of apoptosis in caspase-2-deficient mice // Genes Dev. 1998. V. 12. P. 1304-1314.
61. Woo M., Hakem R., Soengas MS. et al. Essential contribution of caspase 3 / cpp32 to apoptosis and its associated nuclear changes // Genes Dev. 1998. V. 12. P. 806-819.
62. Varfolomeev E.E., Schuchimann M., Luria V. et al. Targeted disruption of the mouse caspase-8 gene ablates cell death induction by the TNF receptors FAS / APO1, and DR3 is lethal prenatally // Immunity. 1998. V. 9. P. 267-276.
63. Haydar T.F., Kuan C.-Y. et al. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase-9 // Cell. 1998. V. 94. P. 325-337.
64. Hakem R., Hakem A., Duncan G.S. Differential requirement for caspase-9 in apoptotic path ways in vivo // Cell. 1998. V. 94. P. 339-352.
65. Nakagawa T., Zhu H., Morishima N. et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta // Nature. 2000. V. 403. P. 98-103.
66. Yeh W.S., de la Pompa J.L., McCurrachetan E. et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis // Science. 1998. V. 279. P. 1954-1958.
67. Zhang J., Cado D., Chen A. et al. FAS-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FAAD / MORT1 // Nature. 1998. V. 332. P. 296-300.
68. Yeh W.S., Itie A., Eplia F. et al. Requirement for casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development // Immunity. 2000. V. 12. P. 633-642.
69. Yoshida H., Kong Y.-Y., Yoshida R. Apaf-1 is required for mitochondria pathways of apoptosis and brain development // Cell. 1998. V. 94. P. 739-750.
70. Li K., Li Y., Shelton J.M. et al. Cytochrome C deficiency causes embryonic lethality and attenuate stress-induced apoptosis // Cell. 2000. V. 101. P. 389-399.
71. Joza N., Susin S., Dangas E. et al. Essential role of the mitohondrial apoptosis-inducing factor in programmed cell death // Nature. 2001. V. 410. No 6828. P. 549-554.
72. Strasser A. Apoptosis signaling // Annu. Rev. Biochem. 2000. V. 60. P. 217-245.
73. Rinkenberger J.L., Horning S., Clocke B. et al. Mcl-1 deficiency results in peri-implantation embryonic lethality // Genes Dev. 2000. V. 14. P. 23-27.
74. Knudson C.M., Tung S.K., Tourtellotte W.G. et al. Bax-deficient mice with lymphoid hyperplasia and male germ cell death // Science. 1995. V. 270. P. 96-99.
75. Deckwerth T.L., Elliott J.L., Knudson C.M. Bax is required for neuronal death after trophic factor deprivation and during development // Neuron. 1996. V. 17. P. 401-411.
76. Meechan T., Loveland K.L., de Kretser D. Developmental regulation of the bcl-2 family during spermatogenesis: insight into the sterility of male mice // Cell Death. Differ. 2001. V. 8. P. 225-233.
77. Lindsten T., Ros A.J., King A. The combined functions of proaptotic bcl-2 family members bak and bax are essential for normal development of multiple tissue // Mol. Cell. 2000. V. 6. P. 1389-1399.
78. Wei M.S., Zong W.-X., Cheng E. et al. Proapoptotic Bax and Bak: a requisite gateway to mitochondrial dysfunction and death // Science. 2001. V. 292. P. 727-730.
79. Yin X.M., Wang K., Gross A. et al. Bid-deficient mice are resistent to Fas-induced hepatocellular apoptosis // Nature. 1999. V. 400. P. 886-891.
80. Bonnillet P., Metcolf T., Huang T. et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and preclude autoimmunity // Science. 1999. V. 286. P. 1735-1738.
81. Rodriquez I., Matsuura K., Khatib A. et al. A Bcl-2 transgene ezpressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection // J. Exptl Med. 1996. V. 183. No 3. P. 1031-1037.
82. Green D.R. Conference "Cell signaling and cancer treatment". Telfs-Buchen (Austria), Report. 1997.
83. Nicholson D.W., Green D.R., Kluck R.M. The release of cytochrome C from mitochondria: a primary sticite for bcl-2 regulation of apoptosis // Science. 1997. V. 275. P. 1132-1136.
84. Whyte M. ICE / CED-3 protease in apoptosis // Trends in Cell Biol. 1996. V. 6. P. 245-248.
85. Nicholson D., Ph.D. Conference "Cell and cancer treatment" Telfs-Buchen (Austria), Report. 1997.
86. Salvesen G.S., Dixit V.M. Caspases: introcellular signaling by proteolysis // Cell. 1997. V. 91. P. 443-446.
87. Erhardt P., Cooper G.M. Activation of the cpp32 apoptotic protease by distinct signaling pathways with differention the sensitivity Bcl-xl // J. Biol. Chem. 1996. V. 271. P. 17601-17610.
88. Schimizu S., Equshi Y., Kanüka W. et al. BCL-2 expression prevents activation of the protease cascade // Oncogene. 1996. V. 12. No 11. P. 2251-2259.
89. Neumeyer D., Farschon D., Reed J. et al. Cell-free apoptosis in Xenopus egg extracts: inhibition by bcl-2 and requirement for an organelle fraction enriched in mitochondria // Cell. 1994. V. 79. P. 353-360.
90. Takahachi A., Alnemri E.S., Lazebnik Y.A. et al. Cleavage of lamin A by Mch2α but not CCP32: multiple interleukin 1β-converting enzyme-related proteases with distinct substrate recognition proporties are active // Proc. Natl Acad. Sci. USA. 1996. V. 93. P. 8395-8401.
91. Yang J., Lin X., Bhala K. et al. Prevention of apoptosis by bcl-2: release of cytochrome C from mitochondria blocked. // Science. 1997. V. 275. No 5288. P. 1129-1133.
92. Wang H.G., Rapp U., Reed J. Bcl-2 targets the protein kinase Raf-1 to mitochondria // Cell. 1996. V. 87. P. 629-638.
93. Ashkenazi A., Dherin V.M. Death receptors. Signaling and modulation. // Science. 1998. V. 281. P. 1305-1308.
94. Yeh W.S. FADD: essential embryo development and signaling from some, but not all, inducers of apoptosis // Science. 1998. V. 279. P. 1954-1958.
95. Wolf B., Green D.R. Suicidal tendencies: apoptotic cell death by caspase family proteinases // J. Biol. Chem. 1999. V. 274. P. 20049-20052.
96. Scaffid C., Fulda S., Scrinivasan A. et al. Two CD95(Apo-I/FAS) signaling pathways // EMBO J. 1998. V. 17. P. 1675-1687.
97. Mercer E.A., Korhonen L., Scoglosa Y. et al. NAIP interacts with hippocalcin and protects neurons against calcium-induced cell death through caspase-3-dependent and independent pathways // EMBO J. 2000. V. 19. P. 3597-3607.
98. Sanna M.G., Correia J., Ducrey O. et al. IAP suppression of apoptosis involves distinct mechanisms: the TAK1/JNK1 signaling cascade and caspase inhibition // Mol. and Cell. Biol. 2002. V. 22. No 6. P. 1754-1766.
99. Korobko E.V., Saschenko L.P., Prockhorchouk E.B. et al. Resistance to tumor necrosis factor induced apoptosis in vitro correlates with high metastatic capacity of cells in vivo // Immunol. Lett. 1999. V. 67. P. 71-76.
100. Thompson C.B. Apoptosis in the pathogenesis and treatment of desease // Science. 1995. V. 267. P. 1456-1462.
101. Holcik M. Do mature red blood cells die by apoptosis? // Trends in Genet. 2002. V. 18. No 3. P. 121.
102. Quarrie L.H., Addey C., Wilde C.J. Programmed cell death during during mammary tissue ibvolution induced by weaning, litter removal, and milk stasis // J. Cell. Physiol. 1996. V. 168. P. 559-569.
103. Fulda S., Wick W., Weller M. et al. Smac agonists sensitise for Apo2L / TRAIL -or anticancer drug-induced apoptosis and induce regression of malignant gliom in vivo // Nature Med. 2002. V. 8. P. 808-815.